A Senate resolution designating May 1 to 7, 2023, as Tardive Dyskinesia Awareness Week
Impact
The resolution emphasizes the need for awareness and education surrounding TD, especially since it is estimated that around 600,000 people in the United States suffer from the condition, with a large portion remaining undiagnosed. By encouraging individuals to become better informed about TD, SR47 aims to foster a greater understanding of the disorder's physical, social, and emotional consequences. Moreover, it highlights the significance of regular monitoring and screening as recommended by the American Psychiatric Association.
Summary
SR47 is a Senate resolution designating May 1 to 7, 2023, as Tardive Dyskinesia Awareness Week. This resolution aims to bring attention to tardive dyskinesia (TD), a movement disorder that can result from the prolonged use of dopamine receptor blocking agents (DRBAs), commonly used to treat various mental health conditions. By raising awareness, the bill seeks to inform the public and healthcare professionals about the symptoms, potential impacts, and the importance of monitoring for TD in patients undergoing treatment with DRBAs.
Sentiment
Overall, the sentiment surrounding SR47 appears to be positive, focusing on the importance of raising awareness and enhancing knowledge about TD. Supporters of the bill generally agree on the necessity to educate both patients and healthcare providers about this disorder, advocate for better monitoring practices, and promote the availability of FDA-approved treatments for TD. The initiative to dedicate a week for awareness is seen as a crucial step in addressing a condition that affects many but often lacks adequate public recognition.
Contention
While specific points of contention were not highlighted in the available text regarding SR47, issues related to mental health awareness and treatment often involve discussions about funding for healthcare initiatives, accessibility to care, and the need for comprehensive education for both healthcare providers and patients. Therefore, discussions surrounding this resolution could potentially touch on broader themes of mental health advocacy and the allocation of resources toward increasing awareness of conditions like tardive dyskinesia.